Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human IL-17RB Biotinylated Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems BAM1207
This item is not returnable.
View return policy
Description
IL-17RB Monoclonal specifically detects IL-17RB in Human samples. It is validated for Western Blot, ELISA Detection (Matched Antibody Pair).Specifications
IL-17RB | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, ELISA Detection (Matched Antibody Pair) 0.5-2.0 ug/mL | |
Q9NRM6 | |
IL17RB | |
Mouse myeloma cell line NS0-derived recombinant human IL-17 RB Arg18-Gly289 Accession # Q9NRM6 | |
50 μg | |
Primary | |
Detects human IL-17 RB in ELISAs and Western blots. In Western blots, no cross-reactivity with recombinant mouse (rm) IL-17 RB, recombinant human IL-17 R, or rmIL-17 R is observed. | |
Human | |
Purified |
Western Blot, ELISA | |
170220 | |
Biotin | |
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. with No Preservative | |
CRL4IL-17 receptor homolog 1, cytokine receptor CRL4, Cytokine receptor-like 4, Evi27, EVI27IL-17B receptor, IL-17 RB, IL-17 receptor B, IL-17 RH1, IL17BRinterleukin 17B receptor, IL-17ER, IL17RB, IL-17RB, IL17Rh1, IL-17Rh1, IL17RH1MGC5245, interleukin 17 receptor B, interleukin 17 receptor homolog 1, interleukin-17 receptor B, Interleukin-17B receptor | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
55540 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction